NCT00017433View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

arsenic trioxide

Trial Locations (6)

30060

Georgia Cancer Specialist, Marietta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

60612

University of Illinois at Chicago, Chicago

80218

Rocky Mountain Cancer Center, Denver

92037

Scripps Clinic, La Jolla

98104

Swedish Cancer Institute, Seattle

Sponsors

Lead Sponsor

CTI BioPharma
All Listed Sponsors
lead

CTI BioPharma

INDUSTRY

NCT00017433 - Arsenic Trioxide in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter